{"id":"W2115861091","doi":"10.1634/theoncologist.2010-0387","title":"Targeting Angiogenesis in Esophagogastric Adenocarcinoma","year":2011,"lang":"en","type":"review","venue":"The Oncologist","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"AstraZeneca; Chugai Pharmaceutical; Pfizer; Amgen","keywords":"Medicine; Sorafenib; Bevacizumab; Sunitinib; Angiogenesis; Internal medicine; Receptor tyrosine kinase; Oncology; Cancer research; Cancer; Vascular endothelial growth factor; Chemotherapy; Receptor; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002039939,0.000294696,0.0001991632,0.0002518359,0.00009674522,0.0003533084,0.0001924125,0.000384358,0.006262898],"category_scores_gemma":[0.0002234311,0.00005853324,0.0001524619,0.0001050415,0.00007228908,0.0002521165,0.0002626945,0.0006641422,0.001369711],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003328872,"about_ca_system_score_gemma":0.000208851,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002418714,"about_ca_topic_score_gemma":0.0005500962,"domain_scores_codex":[0.9999666,0.000006914365,0.000002448765,0.00000332647,0.00001090415,0.0000097989],"domain_scores_gemma":[0.9999413,0.00001049415,0.000006846913,0.000001568629,0.00001573818,0.0000240617],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00138651,0.0008327119,0.002033069,0.001553773,0.0000289413,0.002516343,0.00007106906,0.000730206,0.06991374,0.003459064,0.14819,0.7692845],"study_design_scores_gemma":[0.001079257,0.007917354,0.01477053,0.001370296,0.0001140446,0.01241623,0.0001538022,0.003896402,0.05952024,0.004736005,0.893986,0.00003987939],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2404134,0.4499826,0.01635414,0.06356221,0.02676827,0.0009595522,0.000713791,0.001260096,0.199986],"genre_scores_gemma":[0.4888712,0.3116425,0.01147758,0.02110774,0.01619362,0.0005067456,0.0009696496,0.00014649,0.1490844],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006262898,"threshold_uncertainty_score":0.02095151,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1146690655374631,"score_gpt":0.361694059169733,"score_spread":0.2470249936322699,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}